These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 16196502)
21. Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers. Farooqi AA; Khalid S; Ahmad A Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495357 [TBL] [Abstract][Full Text] [Related]
22. Use of transcription factors as agents and targets for drug development. Smith LM; Birrer MJ Oncology (Williston Park); 1996 Oct; 10(10):1532-8; discussion 1541-2. PubMed ID: 8905845 [TBL] [Abstract][Full Text] [Related]
23. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors. Spandidos DA Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595 [TBL] [Abstract][Full Text] [Related]
24. Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides. Hélène C Eur J Cancer; 1991; 27(11):1466-71. PubMed ID: 1835863 [TBL] [Abstract][Full Text] [Related]
25. Cancer genomics: small RNAs with big impacts. Meltzer PS Nature; 2005 Jun; 435(7043):745-6. PubMed ID: 15944682 [No Abstract] [Full Text] [Related]
26. Family of peptides synthesized in the human body have anticancer effects. Vesely DL Anticancer Res; 2014 Apr; 34(4):1459-66. PubMed ID: 24692673 [TBL] [Abstract][Full Text] [Related]
27. New insights into oncogene addiction found. Garber K J Natl Cancer Inst; 2007 Feb; 99(4):264-5, 269. PubMed ID: 17312299 [No Abstract] [Full Text] [Related]
29. Molecular regulation of angiogenesis and tumorigenesis by signal transduction pathways: evidence of predictable and reproducible patterns of synergy in diverse neoplasms. Arbiser JL Semin Cancer Biol; 2004 Apr; 14(2):81-91. PubMed ID: 15018892 [TBL] [Abstract][Full Text] [Related]
30. The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factors. Seliger B J Immunotoxicol; 2014 Oct; 11(4):308-10. PubMed ID: 24479372 [TBL] [Abstract][Full Text] [Related]
31. Targeting Transcription Factors for Cancer Treatment. Lambert M; Jambon S; Depauw S; David-Cordonnier MH Molecules; 2018 Jun; 23(6):. PubMed ID: 29921764 [TBL] [Abstract][Full Text] [Related]
32. Oncogenes and growth factors in thyroid carcinogenesis. Frauman AG; Moses AC Endocrinol Metab Clin North Am; 1990 Sep; 19(3):479-93. PubMed ID: 2175702 [TBL] [Abstract][Full Text] [Related]
34. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics. Urbanski LM; Leclair N; Anczuków O Wiley Interdiscip Rev RNA; 2018 Jul; 9(4):e1476. PubMed ID: 29693319 [TBL] [Abstract][Full Text] [Related]
35. Extracellular vesicle communication pathways as regulatory targets of oncogenic transformation. Choi D; Lee TH; Spinelli C; Chennakrishnaiah S; D'Asti E; Rak J Semin Cell Dev Biol; 2017 Jul; 67():11-22. PubMed ID: 28077296 [TBL] [Abstract][Full Text] [Related]
37. 14-3-3 proteins as potential oncogenes. Tzivion G; Gupta VS; Kaplun L; Balan V Semin Cancer Biol; 2006 Jun; 16(3):203-13. PubMed ID: 16725345 [TBL] [Abstract][Full Text] [Related]
38. Growth factors and receptors in cancer. Harris AL Curr Opin Biotechnol; 1991 Apr; 2(2):260-8. PubMed ID: 1369356 [TBL] [Abstract][Full Text] [Related]
39. PAX3-FOXO1: Zooming in on an "undruggable" target. Wachtel M; Schäfer BW Semin Cancer Biol; 2018 Jun; 50():115-123. PubMed ID: 29146205 [TBL] [Abstract][Full Text] [Related]
40. Developmental SALL2 transcription factor: a new player in cancer. Hermosilla VE; Hepp MI; Escobar D; Farkas C; Riffo EN; Castro AF; Pincheira R Carcinogenesis; 2017 Jul; 38(7):680-690. PubMed ID: 28430874 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]